What question did this study set out to answer?

To evaluate whether blood pressure-lowering therapy should be provided to all individuals over a certain age or risk threshold rather than restricted to traditional hypertension cut-offs.

August 31, 2009Journal of Clinical HypertensionOpen Access

Blood Pressure–Lowering Treatment Should Be Offered to All Patients Regardless of Blood Pressure

View Full Paper

Ask AI

Bookmark

Why the study?

Does blood pressure-lowering treatment reduce cardiovascular events in all patients over a certain age regardless of baseline blood pressure?

Population

Individuals over a certain age, referencing a systematic review of 161 trials including 464,000 individuals

Design

Editorial

Authors

RMRichard J. McManusGeneral / Preventive / Lipids JMJonathan MantPreventive Cardiology

Discussion

Member takes

Implication

A population-based strategy of offering blood pressure-lowering treatment to all individuals over a certain age, regardless of baseline blood pressure, is biologically plausible and aligns with epidemiological evidence, though practical and economic questions remain.

Key Points

To evaluate whether blood pressure-lowering therapy should be provided to all individuals over a certain age or risk threshold rather than restricted to traditional hypertension cut-offs.
Reviewed findings from a meta-analysis of 161 randomized trials containing 464,000 individuals, evaluating cardiovascular outcomes standardized to a reduction of 10 mm Hg systolic or 5 mm Hg diastolic pressure.
Assessed epidemiological evidence from prospective cohorts covering 1 million adults across varying baseline blood pressures and risk profiles.
Coronary heart disease risk reduction was consistent across baseline systolic pressures from >170 mm Hg down to 110 mm Hg and diastolic pressures from >95 mm Hg down to 70 mm Hg.
Treatment effects were similar for both primary and secondary cardiovascular prevention, aligning with prospective observational data demonstrating linear cardiovascular risk increases down to 115/75 mm Hg.
Proportional benefits were preserved regardless of initial blood pressure, mirroring evidence-based shifts previously adopted in cholesterol management.

Structured PICO

Does blood pressure-lowering treatment reduce cardiovascular events in all patients over a certain age regardless of baseline blood pressure?

Population

Individuals over a certain age, referencing a systematic review of 161 trials including 464,000 individuals

Intervention

Blood pressure-lowering drugs

Outcome

Cardiovascular events (ischemic heart disease and stroke)hard clinical

Limitations

Cost effectiveness compared with a strategy based on identifying and treating high-risk individuals
Detection and management of secondary causes of hypertension
How very high-risk younger individuals will be detected and treated
Whether patients and professionals will accept such a sea change in practice

Cite This Study

McManus et al. (2009) studied this question.

synapsesocial.com/papers/6a8d1d73a4bc1cf4cf7aa61a https://doi.org/10.1111/j.1751-7176.2009.00183.x

Topics

Hypertension management

View Full Paper

Ask AI

Bookmark

Blood Pressure–Lowering Treatment Should Be Offered to All Patients Regardless of Blood Pressure

Discussion

Member takes

Implication

Key Points

Structured PICO

Limitations

Cite This Study

Topics

Blood Pressure–Lowering Treatment Should Be Offered to All Patients Regardless of Blood Pressure

Discussion

Member takes

Implication

Key Points

Structured PICO

Limitations

Cite This Study

Also Consider

Topics

Also Consider